• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

衢州市实施两剂次水痘疫苗免疫策略的影响:一项回顾性出生队列研究。

The impact of the implementation of the two-dose varicella vaccine immunization strategy in Quzhou: A retrospective birth cohort study.

机构信息

School of Public Health, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China.

Department of Immunity, Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang Province, China.

出版信息

Hum Vaccin Immunother. 2024 Dec 31;20(1):2408847. doi: 10.1080/21645515.2024.2408847. Epub 2024 Sep 29.

DOI:10.1080/21645515.2024.2408847
PMID:39344170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11445883/
Abstract

Varicella is a vaccine-preventable disease caused by the varicella zoster virus (VZV), but the varicella incidence among children has increased in recent years. This was a retrospective birth cohort study based on the Zhejiang Provincial Immune Information System (ZJIIS) and the China Information System for Disease Control and Prevention (CISDCP) in Quzhou. A total of 1,291 clinically diagnosed varicella cases born from 2009 to 2014 were collected during 2009-2023, which were analyzed the impact of changes in vaccination strategy on the incidence of varicella based on the Cox-proportional hazards model. It was observed that the onset age of varicella shifted to the older age group and later to 9-11 years. After the change to the two-dose varicella vaccination strategy, the population affected by varicella was concentrated among students and received more than one dose of live attenuated varicella vaccine (VarV). Based on the Coxproportional hazards model and adjusting for all covariates, the risk of varicella infection in children decreased after the introduction of the two-dose varicella vaccination strategy ( = 0.04, 95% : 0.03-0.05). Meanwhile, the Kaplan-Meier curves also showed that the hazards were lower after the change in vaccination strategy. It is recommended that two doses of VarV should be included in the national immunization schedule and that full vaccination should be completed approximately four years after the first dose.

摘要

水痘是由水痘带状疱疹病毒(VZV)引起的可预防疫苗接种疾病,但近年来儿童水痘发病率有所增加。这是一项基于浙江省免疫信息系统(ZJIIS)和中国疾病预防控制信息系统(CISDCP)的回顾性出生队列研究,在衢州进行。共收集了 2009-2023 年期间 2009-2014 年出生的 1291 例临床诊断水痘病例,采用 Cox 比例风险模型分析接种策略变化对水痘发病率的影响。结果显示,水痘发病年龄向大龄组和 9-11 岁后转移。两剂水痘疫苗接种策略改变后,水痘受影响人群集中在学生中,接受了一剂以上的减毒活水痘疫苗(VarV)。基于 Cox 比例风险模型并调整所有协变量后,引入两剂水痘疫苗接种策略后儿童水痘感染风险降低( = 0.04,95%:0.03-0.05)。同时,Kaplan-Meier 曲线也表明接种策略改变后风险降低。建议将两剂 VarV 纳入国家免疫规划,并在第一剂接种后大约四年完成全程接种。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5a/11445883/94be0c10de11/KHVI_A_2408847_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5a/11445883/2a26a28aa54c/KHVI_A_2408847_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5a/11445883/94be0c10de11/KHVI_A_2408847_F0002_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5a/11445883/2a26a28aa54c/KHVI_A_2408847_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad5a/11445883/94be0c10de11/KHVI_A_2408847_F0002_B.jpg

相似文献

1
The impact of the implementation of the two-dose varicella vaccine immunization strategy in Quzhou: A retrospective birth cohort study.衢州市实施两剂次水痘疫苗免疫策略的影响:一项回顾性出生队列研究。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2408847. doi: 10.1080/21645515.2024.2408847. Epub 2024 Sep 29.
2
Analysis of the implementation effect and evaluation of the vaccine protection effect of the live attenuated varicella vaccine program for school-age children in Bao'an district of Shenzhen,China.中国深圳市宝安区儿童水痘减毒活疫苗接种项目实施效果分析及疫苗保护效果评价。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2364485. doi: 10.1080/21645515.2024.2364485. Epub 2024 Jul 25.
3
Effectiveness of two-dose vs. one-dose varicella vaccine in children in Shanghai, China: a prospective cohort study.中国上海两剂与一剂水痘疫苗对儿童有效性的前瞻性队列研究。
Front Public Health. 2024 Jun 4;12:1320407. doi: 10.3389/fpubh.2024.1320407. eCollection 2024.
4
Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study.完全免疫的医护人员中针对水痘带状疱疹病毒的抗体长期持久性:一项义大利回顾性队列研究。
BMC Infect Dis. 2021 May 25;21(1):475. doi: 10.1186/s12879-021-06180-x.
5
Ten year follow-up of healthy children who received one or two injections of varicella vaccine.接受一剂或两剂水痘疫苗的健康儿童的十年随访
Pediatr Infect Dis J. 2004 Feb;23(2):132-7. doi: 10.1097/01.inf.0000109287.97518.67.
6
Varicella prevention in Costa Rica: impact of a one-dose schedule universal vaccination.哥斯达黎加水痘预防:一剂方案普及接种的影响。
Expert Rev Vaccines. 2017 Mar;16(3):229-234. doi: 10.1080/14760584.2017.1247700. Epub 2016 Oct 27.
7
Immunogenicity and safety of an ORF7-deficient skin-attenuated and neuro-attenuated live vaccine for varicella: a randomised, double-blind, controlled, phase 2a trial.ORF7 缺失的减毒活疫苗在皮内和神经内接种的免疫原性和安全性:一项随机、双盲、对照、2a 期临床试验。
Lancet Infect Dis. 2024 Aug;24(8):922-934. doi: 10.1016/S1473-3099(24)00159-2. Epub 2024 Apr 10.
8
Waning Effectiveness of One-dose Universal Varicella Vaccination in Korea, 2011-2018: a Propensity Score Matched National Population Cohort.2011-2018 年韩国一剂次通用水痘疫苗效力降低:一项倾向评分匹配的全国人群队列研究。
J Korean Med Sci. 2021 Sep 13;36(36):e222. doi: 10.3346/jkms.2021.36.e222.
9
Epidemiology of varicella and effectiveness of varicella vaccine in Hangzhou, China, 2019.2019年中国杭州水痘流行病学及水痘疫苗效果
Hum Vaccin Immunother. 2021 Jan 2;17(1):211-216. doi: 10.1080/21645515.2020.1769395. Epub 2020 Jun 23.
10
Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.两剂水痘疫苗接种方案对癌症患儿的免疫原性
Eur J Haematol. 2004 May;72(5):353-7. doi: 10.1111/j.1600-0609.2004.00216.x.

引用本文的文献

1
Changes in Epidemiological Characteristics of Varicella and Breakthrough Cases in Ningbo, China, From 2010 to 2023: Surveillance Study.2010年至2023年中国宁波水痘及突破性病例的流行病学特征变化:监测研究
JMIR Public Health Surveill. 2025 Jun 18;11:e71691. doi: 10.2196/71691.
2
Impact of natural and socio-economic factors on varicella incidence in children in Shanghai, 2013-2022.2013 - 2022年自然因素和社会经济因素对上海儿童水痘发病率的影响
Front Public Health. 2025 May 27;13:1565717. doi: 10.3389/fpubh.2025.1565717. eCollection 2025.

本文引用的文献

1
Epidemiological Characteristics of Varicella Outbreaks - China, 2006-2022.2006 - 2022年中国水痘暴发的流行病学特征
China CDC Wkly. 2023 Dec 29;5(52):1161-1166. doi: 10.46234/ccdcw2023.218.
2
Trends in age-specific varicella incidences following the introduction of the general recommendation for varicella immunization in Germany, 2006-2022.2006-2022 年德国普遍推荐水痘免疫接种后特定年龄水痘发病率的趋势。
BMC Public Health. 2023 Nov 8;23(1):2191. doi: 10.1186/s12889-023-17098-1.
3
Vaccination Coverage by Age 24 Months Among Children Born in 2019 and 2020 - National Immunization Survey-Child, United States, 2020-2022.
2019 年和 2020 年出生的儿童在 24 月龄时的疫苗接种覆盖率-美国国家免疫调查-儿童,2020-2022 年。
MMWR Morb Mortal Wkly Rep. 2023 Nov 3;72(44):1190-1196. doi: 10.15585/mmwr.mm7244a3.
4
Real-World Effectiveness of the Varicella Vaccine among Children and Adolescents in Qatar: A Case-Control Study.卡塔尔儿童和青少年中水痘疫苗的真实世界有效性:一项病例对照研究
Vaccines (Basel). 2023 Oct 5;11(10):1567. doi: 10.3390/vaccines11101567.
5
Associations Between Gender Gaps in Life Expectancy, Air Pollution, and Urbanization: A Global Assessment With Bayesian Spatiotemporal Modeling.预期寿命性别差距、空气污染和城市化之间的关系:基于贝叶斯时空建模的全球评估。
Int J Public Health. 2023 May 10;68:1605345. doi: 10.3389/ijph.2023.1605345. eCollection 2023.
6
Seroprevalence rates in children aged 3-6 years after implementing a two-dose varicella vaccination: A observational study.儿童接种两剂水痘疫苗后 3-6 岁时的血清阳性率:一项观察性研究。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2211465. doi: 10.1080/21645515.2023.2211465. Epub 2023 May 19.
7
The Protective Effectiveness of 2-Dose Varicella Vaccination in Children in Korea: A Case-control Study.韩国 2 剂次水痘疫苗接种儿童的保护效力:病例对照研究。
Pediatr Infect Dis J. 2023 Aug 1;42(8):719-722. doi: 10.1097/INF.0000000000003958. Epub 2023 May 26.
8
Global varicella vaccination programs.全球水痘疫苗接种计划。
Clin Exp Pediatr. 2022 Dec;65(12):555-562. doi: 10.3345/cep.2021.01564. Epub 2022 Nov 2.
9
Monitoring Varicella Vaccine Impact on Varicella Incidence in the United States: Surveillance Challenges and Changing Epidemiology, 1995-2019.监测水痘疫苗对美国水痘发病率的影响:1995-2019 年监测挑战和不断变化的流行病学。
J Infect Dis. 2022 Oct 21;226(Suppl 4):S392-S399. doi: 10.1093/infdis/jiac221.
10
The Effectiveness of Varicella Vaccine: 25 Years of Postlicensure Experience in the United States.水痘疫苗的有效性:美国上市后 25 年的经验。
J Infect Dis. 2022 Oct 21;226(Suppl 4):S425-S430. doi: 10.1093/infdis/jiac299.